Ragavan, Meera
Das, Millie
Article History
First Online: 29 June 2020
Compliance with Ethical Standards
:
: Meera Ragavan declares that she has no conflict of interest. Millie Das has received research funding from Verily, Varian Medical Systems, Celgene, United Therapeutics, AbbVie, Genzyme, and Novarits, and has received consulting fees from Bristol-Myers Squibb (for an educational talk) and AstraZeneca (for an educational podcast).
: This article does not contain any studies with human or animal subjects performed by any of the authors.